Risk factors for Lower Gastrointestinal Bleeding

Written By :  Dr. Nandita Mohan
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-06-01 03:30 GMT   |   Update On 2022-06-01 03:30 GMT

In this systematic review published JAMA Network Open, reports the risk scores for lower gastrointestinal bleeding, the Oakland score was the most discriminative for predicting safe discharge, major bleeding, and need for transfusion, whereas the Strate score was the best at predicting need for hemostasis.Clinical prediction models, or risk scores, can be used to risk stratify patients with...

Login or Register to read the full article

In this systematic review published JAMA Network Open, reports the risk scores for lower gastrointestinal bleeding, the Oakland score was the most discriminative for predicting safe discharge, major bleeding, and need for transfusion, whereas the Strate score was the best at predicting need for hemostasis.

Clinical prediction models, or risk scores, can be used to risk stratify patients with lower gastrointestinal bleeding, although the most discriminative score is unknown. Observational and interventional studies deriving or validating a lower gastrointestinal bleeding risk score for the prediction of a clinical outcome were included. Studies including patients younger than 16 years or limited to a specific patient population or a specific cause of bleeding were excluded. Two investigators independently screened the studies, and disagreements were resolved by consensus.

A total of 3268 citations were identified, the Oakland, Strate, NOBLADS [nonsteroidal anti-inflammatory drug use, no diarrhea, no abdominal tenderness, blood pressure ≤100 mm Hg, antiplatelet drug use (nonaspirin), albumin <3.0 g/dL, disease score ≥2, and BLEED were included in the meta-analysis.

For the prediction of safe discharge, the AUROC for the Oakland score was 0.86. For major bleeding, the AUROC was 0.93 for the Oakland score, 0.73 for the Strate score, 0.58 (95% CI, 0.53-0.62) for the NOBLADS score, and 0.65 for the BLEED score. For transfusion, the AUROC was 0.99 (95% CI, 0.98-1.00) for the Oakland score and 0.88 for the NOBLADS score. For hemostasis, the AUROC was 0.36 for the Oakland score, 0.82 for the Strate score, and 0.24 for the NOBLADS score.

The Oakland score was the most discriminative lower gastrointestinal bleeding risk score for predicting safe discharge, major bleeding, and need for transfusion, whereas the Strate score was best for predicting need for hemostasis. Study suggests that these scores can be used to predict outcomes from lower gastrointestinal bleeding and guide clinical care accordingly concluded the researchers.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News